HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3.

AbstractPURPOSE:
New nitric oxide (NO) donating nonsteroidal anti-inflammatory drugs (NSAIDs) have been synthesized to counteract the side effects of conventional NSAIDs. Mounting evidence suggests that NSAIDs may have a possible chemopreventative/therapeutic role in prostate cancer. NO is a powerful biological messenger with multiple cellular effects. We established the effects of 2 of these new drugs in prostate cell systems.
MATERIALS AND METHODS:
We studied the effects of NO-ibuprofen (NCX 2111) and NO-aspirin (NCX 4060) on hormone sensitive (LNCap) and insensitive (PC3) prostate cancer epithelial cell lines as well as primary cultures of prostatic stroma. Proliferation was measured using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazalium bromide) assay to examine proliferation. Subsequently flow cytometry, cell cycle analysis and TUNEL staining were used to look for apoptosis. Caspase-3 expression was also examined in treated cell types.
RESULTS:
NCX 2111 and NCX 4060 were found to be potent inhibitors of proliferation in a dose dependent fashion. The 2 drugs induced apoptosis, as seen by flow cytometry, cell cycle analysis and TUNEL staining, at doses between 10 and 100 microM. These NO-NSAIDs increased caspase-3 expression. NCX 4060 was more effective at lower concentrations (10 microM) but each compound was much more potent than conventional ibuprofen and aspirin at inducing apoptosis and inhibiting proliferation.
CONCLUSIONS:
NO-NSAIDs are potent antiproliferative pro-apoptotic compounds in prostate cell systems. This pro-apoptotic effect is mediated via caspase-3 and it is independent of the type of prostate cell used. These findings have ramifications for the use of these new drugs in prostate cancer chemoprevention or treatment.
AuthorsJustine Sarah Royle, James A Ross, Ian Ansell, Prasad Bollina, David N Tulloch, Fouad K Habib
JournalThe Journal of urology (J Urol) Vol. 172 Issue 1 Pg. 338-44 (Jul 2004) ISSN: 0022-5347 [Print] United States
PMID15201807 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-(acetyloxy)benzoic acid 6-(nitrooxymethyl)-2-phenylmethyl ester
  • 6-(1,1-dimethylallyl)naringenin
  • Anti-Inflammatory Agents, Non-Steroidal
  • Coloring Agents
  • Flavanones
  • N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester
  • Nitrates
  • Nitric Oxide Donors
  • Tetrazolium Salts
  • Thiazoles
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • thiazolyl blue
  • Aspirin
  • Ibuprofen
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Apoptosis (drug effects)
  • Aspirin (analogs & derivatives, pharmacology)
  • Caspase 3
  • Caspases (physiology)
  • Cell Division (drug effects)
  • Coloring Agents
  • Dose-Response Relationship, Drug
  • Flavanones (chemical synthesis, toxicity)
  • Flow Cytometry
  • Humans
  • Ibuprofen (analogs & derivatives, pharmacology)
  • In Situ Nick-End Labeling
  • Male
  • Nitrates (pharmacology)
  • Nitric Oxide Donors (pharmacology)
  • Prostatic Neoplasms (drug therapy)
  • Tetrazolium Salts
  • Thiazoles
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: